Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

Molecular Dynamics Characterization of Five Pathogenic Factor X Mutants Associated with Decreased Catalytic Activity by Safwat Abdel-Azeim (153436)

Subjects:

DHT increases whereas orchidectomy decreases the weight and cross sectional area of hindlimb muscles. by Young-Eun Yoo (323357)

“…<b>A:</b> In WT mice, DHT increased the GN weight by 7% (212.4±8.8 mg), whereas orchidectomy decreased it by 14% (171.4±9.0 mg) compared with control WT mice (198.4±5.5 mg). …”

Structural details for each point mutation studied by X-ray crystallography in this study. by Aleksi Sutinen (10039145)

Subjects:

Medical expulsive therapy for ureter stone using naftopidil: A multicenter, randomized, double-blind, and placebo-controlled trial by Sung Yong Cho (507514)

“…</p><p>Materials and methods</p><p>Patients diagnosed with a ureter stone were prescribed aceclofenac 100 mg or a combined medication of tramadol 37.5 mg and acetaminophen 325 mg. …”

MMP-2 production is decreased following ALK5 inhibition. by Rebecca A. Scott (488956)

<i>In vivo</i> therapeutic efficacy of VHH-72-Fc lead mutant in SARS-CoV-2 infected hamsters. by Traian Sulea (1549372)

cMSC/Collagen Type I gel fabrication. by Melissa A. MacIver (12850566)

Subjects:

Transcriptional analysis of chondrogenic and osteogenic genes. by Melissa A. MacIver (12850566)

Subjects:

Toluidine blue histology of cMSC constructs for initial chondrogenic screening. by Melissa A. MacIver (12850566)

Subjects:

Immunofluorescence of select extracellular matrix (ECM) components. by Melissa A. MacIver (12850566)

Subjects:

Characterization of passage 1 (P1) bone marrow-derived canine mesenchymal stromal cells (cMSCs). by Melissa A. MacIver (12850566)

Subjects:

TUNEL staining. by Melissa A. MacIver (12850566)

Subjects:

Safranin O and toluidine blue histology. by Melissa A. MacIver (12850566)

Subjects:

Experimental outline. by Melissa A. MacIver (12850566)

Subjects: